Biogen Surges on Promising Alzheimer's Drug Assessment
Published
Nov 04 2020 at 6:14 PM GMT
Key
Points
Points
- The biotech giant received a big boost after US Food and Drug Administration regulators appeared to give a positive assessment of the company's experimental Alzheimer's disease drug, sending shares up 40%.
-
Posted in Business
Trending
Stats
- Published Nov 4, 2020 6:14 PM GMT